Xenetic Biosciences, Inc. (XBIO) is a publicly traded Healthcare sector company. As of June 1, 2026, XBIO trades at $3.15 with a market cap of $7.22M and a P/E ratio of -1.98. XBIO moved -0.32% today. Year to date, XBIO is +45.16%; over the trailing twelve months it is +5.70%. Its 52-week range spans $1.90 to $13.93. Rallies surfaces XBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for XBIO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.15 |
| Market Cap | $7.22M |
| P/E Ratio | -1.98 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.93 |
| 52-Week Low | $1.90 |
| Volume | 8.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.98M |
| Net Income | $-2.68M |
| Gross Margin | 0.00% |
XBIO analyst coverage data. Average price target: $0.00.